- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Organ Transplantation Techniques and Outcomes
- Autopsy Techniques and Outcomes
- Intraperitoneal and Appendiceal Malignancies
- Diversity and Career in Medicine
- Hospital Admissions and Outcomes
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Liver Disease and Transplantation
- Ultrasound in Clinical Applications
- Appendicitis Diagnosis and Management
- Surgical Simulation and Training
- Metastasis and carcinoma case studies
- Hepatitis C virus research
- CAR-T cell therapy research
- Occupational and environmental lung diseases
- Lung Cancer Research Studies
- Biomedical Ethics and Regulation
- Pericarditis and Cardiac Tamponade
- Ethics and Legal Issues in Pediatric Healthcare
- Disaster Response and Management
- Immunotherapy and Immune Responses
Rutgers Cancer Institute of New Jersey
2024
Rutgers, The State University of New Jersey
2024
Memorial Sloan Kettering Cancer Center
2021-2023
Yale University
2017-2018
Yale New Haven Hospital
2017
Abstract Background Mucinous appendiceal adenocarcinomas (MAA) and non-mucinous (NMAA) demonstrate differences in rates patterns of recurrence, which may inform the appropriate extent surgical resection (i.e., appendectomy versus colectomy). The impact on disease-specific survival (DSS) for each histologic subtype was assessed. Patients Methods with resected, non-metastatic MAA NMAA were identified Surveillance, Epidemiology, End Results database (2000–2020). Multivariable models created to...
Background Tumor immune microenvironment (TIME) and cancer antigen expression, key factors for the development of immunotherapies, are usually based on data from primary tumors due to availability tissue analysis; metastatic sites their concordance with tumor lacking. Although same origin tumor, organ-specific differences in TIME metastases may contribute discordant responses checkpoint inhibitor agents. In immunologically ‘cold’ tumors, antigen-targeted chimeric receptor (CAR) T-cell...
To determine the safety and efficacy of adding anti-PD-L1 antibody durvalumab to induction FOLFOX preoperative chemotherapy in locally advanced esophageal adenocarcinoma.
In this SEER-database analysis (https:/
Objective: This study compared outcomes in patients with solid tumor treated for pericardial effusion surgical drainage vs. interventional radiology (IR) percutaneous and incidence of paradoxical hemodynamic instability (PHI) between cohorts. Summary Background Data: Patients advanced-stage malignancies may develop large effusions requiring intervention. PHI is a fatal underreported complication that occurs following drainage. Methods: Clinical characteristics were tumors who underwent s...
Objective: We conducted a prospective trial (NCT01393483) to investigate the utility of serum soluble mesothelin related peptide (SMRP) and tumor expression in management esophageal adenocarcinoma (ADC). Summary Background Data: Clinical ADC is limited by lack accurate evaluation burden, treatment response disease recurrence. Our retrospective data showed that its correlate, SMRP, are overexpressed associated with poor outcomes patients ADC. Methods: Serum SMRP tumoral from 101 locally...
Anatomical resection-often by lobectomy-is the standard of care for patients with early stage NSCLC. With increased diagnosis, survival, and prevalence persons NSCLC, incidence second primary consequently, need contralateral lobectomy a metachronous cancer, is increasing. Perioperative outcomes after are unknown.
Purpose Following the recent publication of an article in The Boston Globe “exposing” common practice scheduling and performing concurrent surgeries, there has been much discussion amongst both lay press hospital administrators seeking to ensure safety patients by investigating regulating this cost-effective strategy. However, is little information about surgeries pediatric patients; even less known parents’ expectations regarding role surgeon on day surgery how these align with those surgeons …